Latest Postherpetic neuralgia Stories
MELBOURNE, Australia, May 27, 2014 /PRNewswire/ -- Expanded SAB will oversee development of EMA401, Company's lead program for
“Those with herpes zoster had a higher incidence of developing major depression,” according to a study published on May 7, 2014 in Psychosomatic Medicine (1).” polyDNA reviews the study
Scilex has commenced with its pivotal bioequivalence study of Ztilido versus Lidoderm® in accordance with FDA recommendations to support approval of Ztilido submitted as a 505(b)(2) NDA
“Some natural treatments may be effective in easing the pain and discomfort of shingles,” according to an article published on Healthline.com on October 28, 2013.
NEWARK, Calif., May 9, 2014 /PRNewswire/ -- Depomed, Inc.
Mr. Sendrow Joins Pharmaceuticals Product Development and Regulatory Expert Eric Floyd, Ph.D.
NEWARK, Calif., April 30, 2014 /PRNewswire/ -- Depomed, Inc.
NEWARK, Calif., April 14, 2014 /PRNewswire/ -- Depomed, Inc.
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/qx6h7s/investigation) has announced the addition of the
Pivotal pharmacokinetic bridging clinical study anticipated to begin in May MALVERN, Pa., March 24, 2014 /PRNewswire/ -- Scilex Pharmaceuticals, Inc., a company engaged in the development
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
- To swell, as grain or wood with water.